A new severity classification tool for diarrhea may help identify which patients will benefit from antibiotic treatment for the condition. Using the new ranking, researchers found patients with severe cases were more responsive to rifamycin (Aemcolo, RedHill Biopharma) than those with moderate bouts.
Diarrhea is the most common foe of the world traveler, and bacteria causes most cases. Antibiotics are the go-to medications for treatment, but medical associations, such as the Infectious Diseases